Next Article in Journal
Physiologically Based Biopharmaceutics Model of Apixaban for Biopharmaceutics Risk Assessment
Previous Article in Journal
Design of Experiment Approach for Enhancing the Dissolution Profile and Robustness of Loratadine Tablet Using D-α-Tocopheryl Polyethylene Glycol 1000 Succinate
Previous Article in Special Issue
Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
 
 
Review

Article Versions Notes

Pharmaceutics 2025, 17(3), 381; https://doi.org/10.3390/pharmaceutics17030381
Action Date Notes Link
article xml file uploaded 17 March 2025 14:09 CET Original file -
article xml uploaded. 17 March 2025 14:10 CET Update https://www.mdpi.com/1999-4923/17/3/381/xml
article pdf uploaded. 17 March 2025 14:10 CET Version of Record https://www.mdpi.com/1999-4923/17/3/381/pdf
article html file updated 17 March 2025 14:11 CET Original file https://www.mdpi.com/1999-4923/17/3/381/html
Back to TopTop